Skip to content

3-Methoxytyramine

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of 3-methoxytyramine, a dopamine breakdown product, in cerebrospinal fluid to evaluate brain dopamine metabolism.

Quick summary

3-MT is a metabolite of dopamine, a key neurotransmitter The test helps diagnose tumors that produce excess catecholamines It may aid in evaluating neurodegenerative diseases like Parkinson's CSF collection via lumbar puncture is required for this test Results are compared against established reference ranges

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
50139-5
Short code
3-MT CSF
Synonyms
3Me-tyramine CSF-sCnc
Category
chemistry
Sample
csf
Container
Polypropylene cryovial (CSF collection tube)
Units
N/A
Ref low
15
Ref high
45
Fasting
false
Population
adult
Sex
all
Age range
≥ 18 years
Method
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
CPT
80349
SNOMED
371441009
Specimen volume
1-2 mL CSF
Stability
Store at -80°C; stable for up to 6 months. Avoid repeated freeze-thaw cycles.
Hemolysis max
200
TAT
168–336 hours
Order
routine

This test is a laboratory examination performed on a sample of your blood, urine, or other body fluid. It helps your doctor evaluate how well your body is working and look for signs of illness that may not be visible during a physical exam.

The 3-Methoxytyramine (3-MT) test measures the amount of 3-MT in your cerebrospinal fluid (CSF). 3-MT is a metabolite produced when dopamine, an important brain neurotransmitter, is broken down. By measuring 3-MT levels, doctors can assess how your body processes dopamine and identify certain neurological conditions.

Your doctor may order this test to confirm or rule out a medical condition, monitor an ongoing health problem, check how well a treatment is working, or screen for potential issues during a routine checkup before symptoms develop.

This test is primarily ordered to help diagnose and monitor conditions related to abnormal dopamine metabolism. It is particularly useful in detecting catecholamine-producing tumors such as pheochromocytoma and paraganglioma. Additionally, it may be used in research settings to evaluate neurodegenerative diseases like Parkinson's disease, where dopamine-producing neurons are affected.

The test is usually performed in a clinic, hospital, or laboratory. A trained professional collects a small sample, often from a vein in your arm, and sends it to the lab for analysis. The procedure is quick, and results are typically ready within a few days.

The test requires a sample of cerebrospinal fluid, which is collected through a procedure called lumbar puncture (spinal tap). During this procedure, a healthcare provider inserts a thin needle between the bones in your lower back to draw out the CSF. The sample is then sent to a laboratory where it is analyzed using specialized techniques to measure 3-MT levels.

Preparation depends on the type of test being done. You may be asked to fast for 8 to 12 hours, avoid certain medications or supplements, or drink plenty of water beforehand. Always follow the specific instructions your healthcare provider gives you.

Your healthcare provider will give you specific instructions before the test. You may need to avoid certain foods, medications, or supplements that could affect catecholamine levels. Be sure to inform your doctor about all medications you are taking. The lumbar puncture procedure itself may require you to lie flat for a period of time afterward.

Reference range

Reference range: 15-45 pmol/mL (may vary by laboratory method and reference population)N/A

Specimen: csf

No special preparation required. Patient should avoid caffeine and dopamine-active medications for 24 hours before collection if possible. Standard lumbar puncture preparation applies.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Elevated 3-MT levels in CSF may indicate increased dopamine turnover or the presence of catecholamine-producing tumors. In pheochromocytoma and paraganglioma, tumor cells produce excess catecholamines, leading to elevated levels of their metabolites including 3-MT. Conversely, reduced 3-MT levels may be associated with certain neurodegenerative conditions affecting dopaminergic neurons. However, interpretation of results requires correlation with clinical symptoms and other diagnostic findings.

Frequently asked questions

Is the lumbar puncture procedure painful?
A lumbar puncture is performed with local anesthesia, so you may feel some pressure but minimal pain during the procedure. You may experience a mild headache afterward, which can be managed with rest and hydration.
How long does it take to get results?
Results typically take several days to a week, as the analysis requires specialized laboratory equipment and techniques.
Are there any risks associated with this test?
The main risks of lumbar puncture include headache, back pain, bleeding, or rare infection. These risks are generally low when performed by experienced healthcare professionals.
Do I need to fast before the test?
Your doctor will provide specific instructions. Some guidelines recommend fasting overnight, but this may vary depending on the purpose of your test.
  1. 1
  2. 2

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy